Glenmark has received USFDA’s approval to sell Rufinamide
The US health regulator USFDA has provided its final approval to the Glenmark Pharmaceuticals for selling Rufinamide which is used to treat seizures caused by...
Download Unicorn Signals App
Powered By EquityPandit
